Furthermore, among HCC patients, IL-6 levels have been found to be increased in advanced vs. early stages of HCC supporting the conception of IL-6 as an important cytokine in hepatocarcinogenesis [21,22]. This evidence concerns the gene IL6 and hepatocellular carcinoma.